A detailed history of Websterrogers Financial Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Websterrogers Financial Advisors, LLC holds 484 shares of LLY stock, worth $398,443. This represents 0.13% of its overall portfolio holdings.

Number of Shares
484
Previous 500 3.2%
Holding current value
$398,443
Previous $442,000 15.61%
% of portfolio
0.13%
Previous 0.16%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 14, 2025

SELL
$727.2 - $932.06 $11,635 - $14,912
-16 Reduced 3.2%
484 $373,000
Q3 2024

Oct 15, 2024

SELL
$772.14 - $960.02 $77,214 - $96,002
-100 Reduced 16.67%
500 $442,000
Q3 2023

Nov 01, 2023

SELL
$434.7 - $599.3 $8,259 - $11,386
-19 Reduced 3.07%
600 $322,000
Q3 2022

Oct 26, 2022

SELL
$296.48 - $337.87 $23,718 - $27,029
-80 Reduced 11.44%
619 $200,000
Q1 2022

Apr 14, 2022

BUY
$234.69 - $291.66 $164,048 - $203,870
699 New
699 $205,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $782B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Websterrogers Financial Advisors, LLC Portfolio

Follow Websterrogers Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Websterrogers Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Websterrogers Financial Advisors, LLC with notifications on news.